These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 22981741)
1. The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats. Reel B; Guzeloglu M; Bagriyanik A; Atmaca S; Aykut K; Albayrak G; Hazan E J Surg Res; 2013 Jun; 182(1):176-84. PubMed ID: 22981741 [TBL] [Abstract][Full Text] [Related]
2. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats. Cao Z; Ye P; Long C; Chen K; Li X; Wang H Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310 [TBL] [Abstract][Full Text] [Related]
3. The effects of alpha-lipoic acid on MMP-2 and MMP-9 activities in a rat renal ischemia and re-perfusion model. Cavdar Z; Ozbal S; Celik A; Ergur BU; Guneli E; Ural C; Camsari T; Guner GA Biotech Histochem; 2014 May; 89(4):304-14. PubMed ID: 24160412 [TBL] [Abstract][Full Text] [Related]
5. Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity. Zou C; Hu H; Xi X; Shi Z; Wang G; Huang X J Surg Res; 2013 Oct; 184(2):1092-5. PubMed ID: 23545406 [TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Villegas I; Martín AR; Toma W; de la Lastra CA Eur J Pharmacol; 2004 Nov; 505(1-3):195-203. PubMed ID: 15556153 [TBL] [Abstract][Full Text] [Related]
8. Mifepristone alleviates cerebral ischemia-reperfusion injury in rats by stimulating PPAR γ. Wu XJ; Sun XH; Wang SW; Chen JL; Bi YH; Jiang DX Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5688-5696. PubMed ID: 30229846 [TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice. Jesse CR; Bortolatto CF; Wilhelm EA; Roman SS; Prigol M; Nogueira CW J Appl Toxicol; 2014 Jan; 34(1):25-32. PubMed ID: 22987311 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Collino M; Aragno M; Mastrocola R; Gallicchio M; Rosa AC; Dianzani C; Danni O; Thiemermann C; Fantozzi R Eur J Pharmacol; 2006 Jan; 530(1-2):70-80. PubMed ID: 16386242 [TBL] [Abstract][Full Text] [Related]
12. Explicit role of peroxisome proliferator-activated receptor gamma in gallic acid-mediated protection against ischemia-reperfusion-induced acute kidney injury in rats. Singh JP; Singh AP; Bhatti R J Surg Res; 2014 Apr; 187(2):631-9. PubMed ID: 24433871 [TBL] [Abstract][Full Text] [Related]
13. Pioglitazone, a Peroxisome Proliferator-Activated Receptor x03B3; Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5/6 Nephrectomized Rat Model. Sun L; Yuan Q; Xu T; Yao L; Feng J; Ma J; Wang L; Lu C; Wang D Cell Physiol Biochem; 2016; 38(5):1831-40. PubMed ID: 27160248 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267 [TBL] [Abstract][Full Text] [Related]
15. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats. Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143 [TBL] [Abstract][Full Text] [Related]
16. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats. Tawfik MK Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400 [TBL] [Abstract][Full Text] [Related]